These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6449280)
1. Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy. Nash CH; Jones SE; Moon TE; Davis SL; Salmon SE Cancer; 1980 Dec; 46(11):2380-8. PubMed ID: 6449280 [TBL] [Abstract][Full Text] [Related]
2. Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer. Lloyd RE; Jones SE; Salmon SE Cancer; 1979 Jan; 43(1):60-5. PubMed ID: 153787 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC). Rainey JM; Jones SE; Salmon SE Cancer; 1979 Jan; 43(1):66-71. PubMed ID: 761176 [TBL] [Abstract][Full Text] [Related]
4. Studies of the combination of adriamycin and cyclophosphamide (alone or with other agents) for the treatment of breast cancer. Salmon SE; Jones SE Oncology; 1979; 36(1):40-7. PubMed ID: 156337 [No Abstract] [Full Text] [Related]
5. [Combination of adriamycin and cyclophosphamide (alone or with other substances) in the treatment of breast cancer]. Salmon SE; Jones SE Onkologie; 1979 Apr; 2(2):45-52. PubMed ID: 93257 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer. Inoue K; Ogawa M; Horikoshi N; Aiba K; Mukaiyama T; Mizunuma N; Itami S; Hirano A; Matsuoka A; Matsumura T Jpn J Clin Oncol; 1991 Oct; 21(5):334-9. PubMed ID: 1753413 [TBL] [Abstract][Full Text] [Related]
7. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial. Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253 [TBL] [Abstract][Full Text] [Related]
8. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity. Hirshaut Y; Kesselheim H Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
10. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy. Abeloff MD; Ettinger DS Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Swenerton KD; Legha SS; Smith T; Hortobagyi GN; Gehan EA; Yap HY; Gutterman JU; Blumenschein GR Cancer Res; 1979 May; 39(5):1552-62. PubMed ID: 427797 [TBL] [Abstract][Full Text] [Related]
12. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706 [TBL] [Abstract][Full Text] [Related]
13. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer. Klefström P Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of advanced breast cancer--actual results ]. Matthes ML; Lenk H; Gürtler R; Tanneberger S Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538 [TBL] [Abstract][Full Text] [Related]
15. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report. Oster MW; Park Y Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin. Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer]. Trofimova NB; Gorbunova VA Antibiotiki; 1983 Aug; 28(8):625-8. PubMed ID: 6638976 [TBL] [Abstract][Full Text] [Related]
18. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. Buzzoni R; Bonadonna G; Valagussa P; Zambetti M J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555 [TBL] [Abstract][Full Text] [Related]
20. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin. Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]